Guillermo Novo bought $2.0M of ASH
Chair of the Board and CEO at ASHLAND INC.. 31,294 shares at an average of $64.24, traded Jan 31, 2025, filed Feb 3, 2025.
Score components
- +25RoleCEO
- +25Trade size$2.0M at market
- +8Relative to holdingsFirst purchase: no shares before this trade
- +14Price context0% above the 52-week low; 27% below the 52-week high
- +8Cluster2 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-25-012349, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jan 31, 2025 | POpen-market purchase Common Stockindirect: By GMGN Novo Family Limited Partnership | +31,294 | $64.24 | $2.0M | 31,294 | Feb 3, 2025 |
Related signals
Other insiders at ASHLAND INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 57Moderate | ASHLAND INC. | Alessandra Faccin Assis SVP and GM, Life Sciences | $202k 3,150 shares | - | |
| 1Weak | ASHLAND INC. | Eric N Boni VP, Finance & Prinpl Acctg Off | $35k 451 shares | -3% | |
| 0Weak | ASHLAND INC. | Robin E. Lampkin SVP, Gen Counsel and Secrty. | $12k 162 shares | -5% | |
| 0Weak | ASHLAND INC. | Robin E. Lampkin SVP, Gen Counsel and Secrty. | $68k 868 shares | -23% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.